Circulating levels of peroxiredoxin 4 as a novel biomarker of oxidative stress in patients with sepsis

Shock

Volumn 35, Issue 5, 2011, Pages 460-465

  Schulte, Janin ^a,b   Struck, Joachim ^a   Köhrle, Josef ^b   Müller, Beat ^c  

^a THERMO FISHER SCIENTIFIC   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

biomarker; oxidative stress; Peroxiredoxin 4; sepsis

Indexed keywords

ALBUMIN; ANTIOXIDANT; BILIRUBIN; C REACTIVE PROTEIN; INTERLEUKIN 6; PEROXIREDOXIN 4; PROCALCITONIN;

ADULT; AGED; APACHE; ARTICLE; CLINICAL TRIAL; CRITICALLY ILL PATIENT; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SCORING SYSTEM; SEPSIS; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT; SURVIVAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

AGED; BIOLOGICAL MARKERS; CRITICAL ILLNESS; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PEROXIREDOXINS; SEPSIS;

EID: 79955528672     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3182115f40     Document Type: Article

References (37)

1. Cepinskas G, Wilson JX: Inflammatory response in microvascular endothelium in sepsis: role of oxidants. J Clin Biochem Nutr 42:175-184, 2008. (Pubitemid 351916671)
2. Mishra V: Oxidative stress and role of antioxidant supplementation in critical illness. Clin Lab 53:199-209, 2007. (Pubitemid 46656577)
3. Riedemann NC, Guo RF, Ward PA: Novel strategies for the treatment of sepsis. Nat Med 9:517-524, 2003. (Pubitemid 36597096)
4. Crimi E, Sica V, Williams-Ignarro S, Zhang H, Slutsky AS, Ignarro LJ, Napoli C: The role of oxidative stress in adult critical care. Free Radic Biol Med 40: 398-406, 2006. (Pubitemid 43140741)
5. Pinsky MR: Dysregulation of the immune response in severe sepsis. Am J Med Sci 328:220-229, 2004. (Pubitemid 39372464)
6. Oldham KM, Bowen PE: Oxidative stress in critical care: is antioxidant supplementation beneficial? J Am Diet Assoc 98:1001-1008, 1998. (Pubitemid 28409310)
7. Berger MM, Chioléro RL: Antioxidant supplementation in sepsis and systemic inflammatory response syndrome. Crit Care Med 35:S584-S590, 2007. (Pubitemid 47312199)
8. Wood ZA, Schröder E, Harris JR, Poole LB: Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci 28:32-40, 2003. (Pubitemid 36051004)
9. Haridas V, Ni J, Meager A, Su J, Yu GL, Zhai Y, Kyaw H, Akama KT, Hu J, Van Eldik LJ, et al.: TRANK, a novel cytokine that activates NF-kappa B and c-Jun N-terminal kinase. J Immunol 161:1-6, 1998. (Pubitemid 28285498)
10. Jin D-Y, Chae HZ, Rhee SG, Jeang K-T: Regulatory role for a novel human thioredoxin peroxidase in NF-kB activation. J Biol Chem 272:30952-30961, 1997. (Pubitemid 27527539)
11. Okado-Matsumoto A, Matsumoto A, Fujii J, Taniguchi N: Peroxiredoxin IV is a secretable protein with heparin-binding properties under reduced conditions. J Biochem 127:493-501, 2000. (Pubitemid 30185255)
12. Schulte J, Struck J, Bergmann A, Köhrle J: Immunoluminometric assay for quantification of peroxiredoxin 4 in human serum. Clin Chim Acta 411: 1258-1263, 2010.
13. Yu S, Mu Y, Ao J, Chen X: Peroxiredoxin IV regulates pro-inflammatory responses in large yellow croaker (Pseudosciaena crocea) and protects against bacterial challenge. J Proteome Res 9:1424-1436, 2010.
14. Christ-Crain M, Morgenthaler NG, Struck J, Harbarth S, Bergmann A, Muller B: Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study. Crit Care 9:R816-R824, 2005.
15. Morgenthaler NG, Struck J, Christ-Crain M, Bergmann A, Muller B: Pro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score: an observational study. Crit Care 9:R37-R45, 2005.
16. Müller B, Becker KL, Kränzlin M, Schächinger H, Huber PR, Nylèn ES, Snider RH, White JC, Schmidt-Gayk H, Zimmerli W, et al.: Disordered calcium homeostasis of sepsis: association with calcitonin precursors. Eur J Clin Invest 30:823-831, 2000.
17. Müller B, Becker KL, Schachinger H, Rickenbacher PR, Huber PR, Zimmerli W, Ritz R: Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 28:977-983, 2000.
18. Müller B, Peri G, Doni A, Perruchoud AP, Landmann R, Pasqualini F, Mantovani A: High circulating levels of the IL-1 type II decoy receptor in critically ill patients with sepsis: association of high decoy receptor levels with glucocorticoid administration. J Leukoc Biol 72:643-649, 2002. (Pubitemid 36277834)
19. Müller B, Peri G, Doni A, Torri V, Landmann R, Bottazzi B, Mantovani A: Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients. Crit Care Med 29:1404-1407, 2001.
20. Schütz P, Christ-Crain M, Morgenthaler NG, Struck J, Bergmann A, Müller B: Circulating precursor levels of endothelin-1 and adrenomedullin, two endothelium-derived, counteracting substances, in sepsis. Endothelium 14: 345-351, 2007.
21. Castella X, Artigas A, Bion J, Kari A: A comparison of severity of illness scoring systems for intensive care unit patients: results of a multicenter, multinational study. The European/North American Severity Study Group. Crit Care Med 23:1327-1335, 1995.
22. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG: The SOFA (Sepsis-Related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of theWorking Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707-710, 1996. (Pubitemid 26254283)
23. Vincent JL, Ferreira F, Moreno R: Scoring systems for assessing organ dysfunction and survival. Crit Care Clin 16:353-366, 2000. (Pubitemid 30193854)
24. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644-1655, 1992.
25. Chang X, Cui Y, Zong M, Zhao Y, Yan X, Chen Y, Han J: Identification of proteins with increased expression in rheumatoid arthritis synovial tissues. J Rheumatol 36:872-880, 2009.
26. Leaver SK, MacCallum NS, Pingle V, Hacking MB, Quinlan GJ, Evans TW, Burke-Gaffney A: Increased plasma thioredoxin levels in patients with sepsis: positive association with macrophage migration inhibitory factor. Intensive Care Med 36:336-341, 2010.
27. Power C, Fanning N, Redmond HP: Cellular apoptosis and organ injury in sepsis: a review. Shock 18:197-211, 2002.
28. Mitaka C, Hirata Y, Yokoyama K, Wakimoto H, Hirokawa M, Nosaka T, Imai T: Relationships of circulating nitrite/nitrate levels to severity and multiple organ dysfunction syndrome in systemic inflammatory response syndrome. Shock 19:305-309, 2003.
29. Andresen M, Regueira T, Bruhn A, Perez D, Strobel P, Dougnac A, Marshall G, Leighton F: Lipoperoxidation and protein oxidative damage exhibit different kinetics during septic shock. Mediators Inflamm 2008:168652, 2008.
30. De Vega JMA, D́az J, Serrano E, Carbonell LF: Plasma redox status relates to severity in critically ill patients. Crit Care Med 28:1812-1814, 2000.
31. Chuang CC, Shiesh SC, Chi CH, Tu YF, Hor LI, Shieh CC, Chen MF: Serum total antioxidant capacity reflects severity of illness in patients with severe sepsis. Crit Care 10:R36, 2006.
32. Cighetti G, Paroni R, Marzorati S, Borotto E, Giudici R, Magnanini G, Iapichino G: Evaluation of oxidative stress in serum of critically ill patients by a commercial assay and gas chromatography-mass spectrometry. Clin Chem 51:1515-1517, 2005. (Pubitemid 41060889)
33. Doise JM, Aho LS, Quenot JP, Guilland JC, Zeller M, Vergely C, Aube H, Blettery B, Rochette L: Plasma antioxidant status in septic critically ill patients: a decrease over time. Fundam Clin Pharmacol 22:203-209, 2008. (Pubitemid 351392956)
34. Mishra V, Baines M, Wenstone R, Shenkin A: Markers of oxidative damage, antioxidant status and clinical outcome in critically ill patients. Ann Clin Biochem 42:269-276, 2005. (Pubitemid 40961744)
35. Hofer S, Rosenhagen C, Nakamura H, Yodoi J, Bopp C, Zimmermann JB, Goebel M, Schemmer P, Hoffmann K, Schulze-Osthoff K, et al.: Thioredoxin in human and experimental sepsis. Crit Care Med 37:2155-2159, 2009.
36. Warner A, Bencosme A, Healy D, Verme C: Prognostic role of antioxidant enzymes in sepsis: preliminary assessment. Clin Chem 41:867-871, 1995.
37. Luchtemberg MN, Petronilho F, Constantino L, Gelain DP, Andrades M, Ritter C, Moreira JC, Streck EL, Dal-Pizzol F: Xanthine oxidase activity in patients with sepsis. Clin Biochem 41:1186-1190, 2008.